logo
logo

Maravai LifeSciences acquires assets and intellectual property from Molecular Assemblies to enhance nucleic acid synthesis capabilities

Jan 28, 2025•9 months ago

Acquiring Company

Maravai LifeSciences

Acquired Company

Molecular Assemblies

San DiegoSan DiegoBiotechnologyHealth CareBiotechnology

Description

Maravai LifeSciences, Inc. has announced its acquisition of intellectual property and assets from Molecular Assemblies, Inc. This strategic move will expand Maravai and TriLink BioTechnologies' ability to enable customers to develop next-generation mRNA and CRISPR nucleic acid-based therapies, as well as enhance their workflows for oligo length, purity, and cost efficiency.

Company Information

Company

Maravai LifeSciences

Location

San Diego, California, United States

About

Maravai LifeSciences is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines, and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world’s leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed